Citation 139818

JODYNIS-LIEBERT,J: MURIAS,M: BLOSZYK,E:. (1999). EFFECT OF SEVERAL SESQUITERPENE LACTONES OF LIPID PEROXIDATION AND GLUTATHIONE LEVEL.. 65(4)

Citation Details

Title	EFFECT OF SEVERAL SESQUITERPENE LACTONES OF LIPID PEROXIDATION AND GLUTATHIONE LEVEL.
Authors	JODYNIS-LIEBERT,J: MURIAS,M: BLOSZYK,E:
Year	1999
Volume	65
Issue	4

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HELENALIN	INACTIVE
2	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HELENALIN	ACTIVE
3	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	INACTIVE
4	GLUTATHIONE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	ACTIVE
5	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	ACTIVE
6	ASPARTATE AMINOTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	WEAK ACTIVITY
7	ALANINE AMINOTRANSFERASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	WEAK ACTIVITY
8	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEXICANIN I	INACTIVE
9	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEXICANIN I	ACTIVE
10	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	INACTIVE
11	GLUTATHIONE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	ACTIVE
12	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	ACTIVE
13	ASPARTATE AMINOTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	WEAK ACTIVITY
14	ALANINE AMINOTRANSFERASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	WEAK ACTIVITY
15	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GEIGERININ	INACTIVE
16	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GEIGERININ	ACTIVE
17	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	INACTIVE
18	GLUTATHIONE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	WEAK ACTIVITY
19	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	ACTIVE
20	ASPARTATE AMINOTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	WEAK ACTIVITY
21	ALANINE AMINOTRANSFERASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	WEAK ACTIVITY
22	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LINIFOLIN A	INACTIVE
23	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LINIFOLIN A	ACTIVE
24	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	INACTIVE
25	GLUTATHIONE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	WEAK ACTIVITY
26	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
27	ASPARTATE AMINOTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	WEAK ACTIVITY
28	ALANINE AMINOTRANSFERASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	WEAK ACTIVITY
29	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	INACTIVE
30	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	ACTIVE
31	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	INACTIVE
32	GLUTATHIONE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	WEAK ACTIVITY
33	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	ACTIVE
34	ASPARTATE AMINOTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	WEAK ACTIVITY
35	ALANINE AMINOTRANSFERASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	WEAK ACTIVITY
36	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASPERILIN	INACTIVE
37	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASPERILIN	ACTIVE
38	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	INACTIVE
39	GLUTATHIONE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	ACTIVE
40	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	ACTIVE
41	ASPARTATE AMINOTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	WEAK ACTIVITY
42	ALANINE AMINOTRANSFERASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	WEAK ACTIVITY
43	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TELEKIN	INACTIVE
44	HYDROXIDE RADICAL GENERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TELEKIN	ACTIVE
45	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	INACTIVE
46	GLUTATHIONE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	ACTIVE
47	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	ACTIVE
48	ASPARTATE AMINOTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	WEAK ACTIVITY
49	ALANINE AMINOTRANSFERASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	WEAK ACTIVITY

Citation 139818

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1